Q2, 2011

The pharmaceutical industry has typically been slow to adopt new data collection technology when it comes to clinical development. And to some degree this is understandable when you are working in a highly regulated industry where patient safety is the highest priority. Why change a proven process?

However, over the past decade we have witnessed the industry's almost total acceptance of electronic data capture (EDC) technology and the growing acceptance of electronic patient reported outcomes (ePRO) applications.

Respondents provided their satisfaction with product attributes like human-machine interface, technical support, EDC page load speed, ePRO reporting portal, and integration capabilities, just to name a few. You may be surprised to find that providers that rate high on brand familiarity and use are not necessarily those that garner the highest satisfaction ratings.

Report Content:

This report contains the following four sections.

1. High-level takeaways and implications - In this section we lay out what the data in this report is telling us and how it could impact your development strategies and operations. The goal of this section is to arm you with usable recommendations that can impact your current and future operations.

2. EDC service provider section – This section focuses on how Principal Investigators and Site Coordinators view the various aspects and market dynamics as they relate to Electronic Data Capture. These include:
Adoption and preference for EDC
Service provider brand leadership and performance

3. ePRO service provider section – This section focuses on how Principal Investigators and Site Coordinators view the various aspects and market dynamics as they relate to Electronic Patient Reported Outcomes. These include:

• Adoption and preference for ePRO
• Service provider brand leadership and performance

4. Trends and ideas impacting clinical development – In the end a sponsor or service provider wants to lock patient data on-time. This section ties together respondents’ views of how these technologies can and could improve the speed of and general conduct of clinical development studies.

As always, an appendix of Charts and Graphs is also included within this report with responses to all questions asked in this study.

What Readers Will Learn From This Report:

Sponsors and CROs How to select a technology partner that enhances your relationships with sites Preferences for specific EDC and ePRO applications What study types users believe are least suited for the technologies Current and future adoption estimates for ePRO Which technology providers have the best and worst integration capabilities with other technologies	Technology Providers Their own brand's strength vs. competing providers Product adoption profiles for all major brands Detailed performance profiles for all major technology providers across critical success factors Competitive strengths and weaknesses Product satisfaction profiles across all major brands Technology users' brand preferences
EDC Vendors Profiled: DSG DataLabs DATATRAK Etrials/Merge Healthcare Medidata Rave Oracle Remote Data Capture (RDC) Phase Forward InForm Phoenix Data Systems	ePRO Vendors Profiled: Almac Arrowhead CRF Inc ERT ICOPhone Invivodata PHT Symfo
Other Measurements Reported: Human-machine Interface Query Process Speed/ Page Loads Technical Support Integration Capabilities Overall Satisfaction Similar Reports: Purchasers of this report also purchased: 2011 CRO Quality Benchmarking The Future of Clinical Monitoring Patient and Investigator Recruitment Success	Sample Graph: